A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (5), 831-836
- https://doi.org/10.1016/s0168-8278(94)80246-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary reportJournal of Gastroenterology and Hepatology, 1993
- Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitisJournal of Hepatology, 1992
- A prospective study of post‐transfusion non‐A, non‐B (type C) hepatitis following cardiovascular surgery in TaiwanJournal of Medical Virology, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virusHepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Non-A, Non-B Hepatitis: Evolving Epidemiologic and Clinical PerspectiveSeminars in Liver Disease, 1986